The Institute for Neurodegenerative Disorders

New Haven, Connecticut 06510

We've found

3 trials

at this facility

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

Status: Enrolling, Phase II
Updated: 8/7/2017

from

New Haven, CT

Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)

Status: Enrolling
Updated: 1/18/2012

from

New Haven, CT

Systemic Synuclein Sampling Study (S4)

Status: Enrolling
Updated: 3/24/2016

from

New Haven, CT

Use our guide to learn which trials are right for you!